Preclinical and first-in-human evaluation of AL002, a novel TREM2 agonistic antibody for Alzheimer’s disease
Ilaria Tassi, Tuan D. Nguyen, Balasubrahmanyam Budda, Michael E. Ward et al.
Citations
74 citations
Journal
Alzheimer s Research & Therapy
Topics
Inflammation biomarkers and pathways
Field-Weighted Citation Impact (FWCI)
17.80
article
Preclinical and first-in-human evaluation of AL002, a novel TREM2 agonistic antibody for Alzheimer’s disease
Ilaria Tassi, Tuan D. Nguyen, Balasubrahmanyam Budda, Michael E. Ward, Anna Rychkova, Hervé Rhinn, Tina Schwabe, Brady Burgess, Felix L. Yeh, Adam Simmons, Robert Paul, Arthur J. Mayorga, Hua Long, Arnon Rosenthal, Sara Kenkare-Mitra
article en
74 citations
Abstract
No abstract available for this paper.
Publication Tag
Alzheimer s Research & TherapyVol. 16(1)
Institutions
Massachusetts Academy of Math and Science at WPI (US), Rapt Therapeutics (United States) (US), Film Independent (US), Alector (United States) (US), Apple (United States) (US)